Market closed
Innoviva/$INVA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Innoviva
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Ticker
$INVA
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
112
Website
Innoviva Metrics
BasicAdvanced
$1.2B
Market cap
19.11
P/E ratio
$0.99
EPS
0.57
Beta
-
Dividend rate
Price and volume
Market cap
$1.2B
Beta
0.57
52-week high
$20.14
52-week low
$14.33
Average daily volume
737K
Financial strength
Current ratio
12.556
Quick ratio
11.022
Long term debt to equity
77.671
Total debt to equity
77.671
Interest coverage (TTM)
8.56%
Management effectiveness
Return on assets (TTM)
10.36%
Return on equity (TTM)
9.97%
Valuation
Price to earnings (TTM)
19.112
Price to revenue (TTM)
3.366
Price to book
1.77
Price to tangible book (TTM)
2.68
Price to free cash flow (TTM)
7.328
Growth
Revenue change (TTM)
21.46%
Earnings per share change (TTM)
45.94%
3-year revenue growth (CAGR)
-1.99%
3-year earnings per share growth (CAGR)
-31.52%
What the Analysts think about Innoviva
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Innoviva stock.
Innoviva Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Innoviva Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Innoviva stock?
Innoviva (INVA) has a market cap of $1.2B as of December 13, 2024.
What is the P/E ratio for Innoviva stock?
The price to earnings (P/E) ratio for Innoviva (INVA) stock is 19.11 as of December 13, 2024.
Does Innoviva stock pay dividends?
No, Innoviva (INVA) stock does not pay dividends to its shareholders as of December 13, 2024.
When is the next Innoviva dividend payment date?
Innoviva (INVA) stock does not pay dividends to its shareholders.
What is the beta indicator for Innoviva?
Innoviva (INVA) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.